Is this you? Create Your Porfile
Avatar

Yiqing Zhou

Kosan Biosciences

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Yiqing Zhou is active.

Explore More

Publication

Featured researches published by Yiqing Zhou.

Archive | 2004

Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites

Robert Johnson; Yiqing Zhou; Thomas Muller

Archive | 2004

Method for treating diseases using hsp90-inhibiting agents in combination with immunosuppressants

Robert Johnson; Yiqing Zhou; Thomas Muller

Archive | 2004

Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors

Robert Johnson; Yiqing Zhou; Thomas Muller

Archive | 2004

Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes

Robert Johnson; Yiqing Zhou; Thomas Muller

Archive | 2003

EPO D + 5-FU/gemcitabine

Yiqing Zhou; Robert Johnson

Archive | 2004

Method for treating diseases using hsp90-inhibiting agents in combination with nuclear export inhibitors

Robert Johnson; Yiqing Zhou; Thomas Muller

Archive | 2006

Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitor

Robert Johnson; Alison L. Hannah; Gillian F. Cropp; Yiqing Zhou; J. Sherrill

Cancer Chemotherapy and Pharmacology | 2012

Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors

Elaine T. Lam; Sanjay Goel; Larry J. Schaaf; Gillian F. Cropp; Alison L. Hannah; Yiqing Zhou; Barbara McCracken; Brandi I. Haley; Robert Johnson; Sridhar Mani; Miguel A. Villalona-Calero

Archive | 2006

Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor

Robert Johnson; Alison L. Hannah; Gillian F. Cropp; Yiqing Zhou; J. Sherrill

Cancer Research | 2004

KOS-862 (epothilone D) and 5’-deoxy-5-fluorouridine or 5-fluorouracil in human breast cancer cells: Marked synergistic antitumor effects and induction of thymidine phosphorylase expression

Yiqing Zhou; Jie Lin; Robert Johnson

Explore More

Collaboration

Dive into the Yiqing Zhou's collaboration.

Top Co-Authors
Avatar

Robert Johnson

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

Thomas Muller

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

Alison L. Hannah

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

Gillian F. Cropp

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

J. Sherrill

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

Barbara McCracken

Ohio State University

View shared research outputs
Top Co-Authors
Avatar

Brandi I. Haley

Ohio State University

View shared research outputs
Top Co-Authors
Avatar

Elaine T. Lam

Ohio State University

View shared research outputs
Top Co-Authors
Avatar

J. Michael Sherrill

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

Jie Lin

Kosan Biosciences

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge